PWMAG
GSK icon

Pinnacle Wealth Management Advisory Group’s GSK GSK Stock Holding History

Pinnacle Wealth Management Advisory Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,808
Closed -$228K – 180
2020
Q1 		$228K Buy
+4,808
New +$256K 0.11% 137

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Pinnacle Wealth Management Advisory Group's GSK Position: Q2 2020 in Review

Pinnacle Wealth Management Advisory Group sold out of GSK (GSK) in Q2 2020, closing a stake of 4,808 shares — an estimated $228K sold.

Pinnacle Wealth Management Advisory Group first reported a position in GSK in Q1 2020 and held it in 1 quarter. The position peaked at $228K in Q1 2020. 840 funds tracked by Wall St. Rank hold GSK as of Q2 2020.

  • Pinnacle Wealth Management Advisory Group reported no remaining GSK position as of Q2 2020 after selling out during the quarter.
  • Pinnacle Wealth Management Advisory Group sold 4,808 GSK shares in Q2 2020, an estimated $228K.
  • Pinnacle Wealth Management Advisory Group first reported a position in GSK in Q1 2020 and held it in 1 quarter.
  • Pinnacle Wealth Management Advisory Group's GSK position peaked at $228K in Q1 2020.
  • 840 funds tracked by Wall St. Rank held GSK as of Q2 2020.

Based on Pinnacle Wealth Management Advisory Group's 13F filing for Q2 2020, filed 11 Aug 2020.